Variant report
Variant | esv1823341 |
---|---|
Chromosome Location | chr2:125107948-125109738 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7567224 | chr2:125107948-125107949 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs566332207 | chr2:125108001-125108002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs779999 | chr2:125108025-125108026 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs372122951 | chr2:125108030-125108031 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs71641606 | chr2:125108031-125108032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs187642792 | chr2:125108050-125108051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs779998 | chr2:125108051-125108052 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs76777282 | chr2:125108052-125108053 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs545863336 | chr2:125108073-125108074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs191957724 | chr2:125108085-125108086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs576002748 | chr2:125108122-125108123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs561354065 | chr2:125108150-125108151 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs181009838 | chr2:125108162-125108163 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs539449373 | chr2:125108189-125108190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs796641 | chr2:125108191-125108192 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs11378065 | chr2:125108208-125108209 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs140247591 | chr2:125108311-125108312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs115983630 | chr2:125108342-125108343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs7582767 | chr2:125108364-125108365 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs185896915 | chr2:125108398-125108399 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs201142358 | chr2:125108443-125108444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs7609391 | chr2:125108452-125108453 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs376922329 | chr2:125108453-125108454 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs570025277 | chr2:125108462-125108463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs529293849 | chr2:125108526-125108527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs549360573 | chr2:125108537-125108538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs111584791 | chr2:125108570-125108571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs201425191 | chr2:125108574-125108575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs398090612 | chr2:125108575-125108576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs531542317 | chr2:125108580-125108581 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs548445152 | chr2:125108610-125108611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs190169348 | chr2:125108613-125108614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs182439206 | chr2:125108624-125108625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs558418727 | chr2:125108637-125108638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs571797412 | chr2:125108638-125108639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs537213088 | chr2:125108647-125108648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs556245306 | chr2:125108720-125108721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs576007280 | chr2:125108793-125108794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs568238832 | chr2:125108851-125108852 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs187395043 | chr2:125108890-125108891 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs143978718 | chr2:125108952-125108953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs527498981 | chr2:125109003-125109004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs115631910 | chr2:125109160-125109161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs566626276 | chr2:125109189-125109190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs114003282 | chr2:125109239-125109240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs564159171 | chr2:125109286-125109287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs558566248 | chr2:125109297-125109298 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs190351521 | chr2:125109316-125109317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs114863694 | chr2:125109349-125109350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs529359308 | chr2:125109442-125109443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Mental retardation | 17621639 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neurocytoma | 17123091 | CNVD |
Developmental delay | 21147756 | CNVD |
Bladder cancer | 21909424 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:125105200-125108800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
2 | chr2:125108800-125109000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr2:125108800-125109600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr2:125109600-125109800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |